HPV Vaccination Rates in Mid-Adult and High-Risk Patients: Strategies for Improvement
b'Host: Anna Giuliano, PhD
\\n\\n Guest: Joel Heidelbaugh, MD
\\n\\n\\n \\n
HPV vaccination guidance for mid-aged adults (27 to 45 years old) was updated by the CDC in 2019. Unfortunately, very few individuals in the US in this age range have ever been vaccinated for HPV, despite the risk for acquiring an HPV infection that can potentially progress to cancer, most notably oropharyngeal, cervical, and anorectal. Join us as Drs. Anna Giuliano and Joel Heidelbaugh discuss strategies for improving HPV vaccination rates across different populations and provide specifics on how and when to use shared clinical decision-making (SCDM) when offering a permissive recommendation.
'